Frazier Life Sciences
Frazier Life Sciences is an SEC-registered investment adviser based in Palo Alto, CA. It reports advising 4 venture funds, with $7B in gross private fund assets as of its Form ADV filed Mar 31, 2026.
Focus
Not known yet. The SEC does not ask a firm what stages or sectors it invests in. Once the firm claims this profile, or rounds it invested in are recorded, it will show here with its source.
Portfolio
No rounds recorded yet. A round appears here when a press release, news report or the company names this firm as an investor, with a link to that source.
People
- Daniel J. EstesMember of the General Partner of the General PartnerLast named Mar 17, 2025
- James N. TopperMember of the General Partner of the General PartnerLast named Mar 17, 2025
- Patrick J. HeronMember of the General Partner of the General PartnerLast named Mar 17, 2025
A fund's Form D names the executive officers and directors of its general partner when it is filed. People stay listed with the date they were last named; someone who has left may still appear until a newer filing or a correction says so.
Funds
| Fund | Formed | Raised | Target | Last filed |
|---|---|---|---|---|
| Frazier Life Sciences XII, L.P. | 2025 | — | Indefinite | Mar 17, 2025 |
| Frazier Life Sciences XI, L.P. | 2022 | $960M | $960M | Mar 18, 2022 |
Funds are matched to this firm by the manager named on their filings or by name. If a fund here is not theirs, tell us below.
Is something here wrong or out of date?
Tell us what has changed and, if you can, where it says so. An editor checks it against a source before the profile changes. If this profile is about your firm, you can also claim it and keep it current yourself.